(Q42632473)

English

Efficacy and tolerability of intravenous paricalcitol in calcitriol-resistant hemodialysis patients with secondary hyperparathyroidism: 12-month prospective study

scientific article published on 17 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Efficacy and tolerability of intravenous paricalcitol in calcitriol-resistant hemodialysis patients with secondary hyperparathyroidism: 12-month prospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

hyperparathyroidism

1 reference

based on heuristic

inferred from title

secondary hyperparathyroidism

1 reference

based on heuristic

inferred from title

author name string

Halil Zeki Tonbul

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Yalcin Solak

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Huseyin Atalay

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Kultigin Turkmen

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Lutfullah Altintepe

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

17 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

297-303

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Vitamin D deficiency and secondary hyperparathyroidism among patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Consequences and management of hyperphosphatemia in patients with renal insufficiency

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Management of Secondary Hyperparathyroidism: The Importance and the Challenge of Controlling Parathyroid Hormone Levels without Elevating Calcium, Phosphorus, and Calcium-Phosphorus Product

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

New vitamin D analogs and changing therapeutic paradigms

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Vitamin D analogs: therapeutic applications and mechanisms for selectivity

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Paricalcitol capsules for the control of secondary hyperparathyroidism in chronic kidney disease

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Intravenous calcitriol versus paricalcitol in haemodialysis patients with severe secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Paricalcitol as compared with calcitriol in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure.

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2011.647298

21 January 2018

Identifiers

10.3109/0886022X.2011.647298

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42632473&oldid=2087075851"